Why Should You Put Bristol-Myers Squibb Co (NYSE: BMY) On Your Portfolio?
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of -6.98% and -7.26% over the past three months. BMY shares are trading -9.23% year to date (YTD), with the 12-month market performance up to 4.52% higher. […]
Bristol-Myers Squibb Co (NYSE: BMY) – Suitable For Long Term Buy?
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of -9.51% and -2.44% over the past three months. BMY shares are trading -2.42% year to date (YTD), with the 12-month market performance up to 7.37% higher. […]
Do Bristol-Myers Squibb Co (NYSE: BMY) Fit In A Value Investing Philosophy?
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of -0.10% and 5.16% over the past three months. BMY shares are trading 7.83% year to date (YTD), with the 12-month market performance up to 14.54% higher. […]
Bristol-Myers Squibb Co (NYSE: BMY) Has Another Chance To Impress You
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of 3.49% and 5.93% over the past three months. BMY shares are trading 7.97% year to date (YTD), with the 12-month market performance up to 17.90% higher. […]
Is Bristol-Myers Squibb Co (NYSE: BMY) Back In The Buying Zone?
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of -4.94% and 5.90% over the past three months. BMY shares are trading 6.06% year to date (YTD), with the 12-month market performance up to 13.94% higher. […]
Bristol-Myers Squibb Co (NYSE: BMY): Stock That Needs Special Handling
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of 2.47% and 4.09% over the past three months. BMY shares are trading 8.01% year to date (YTD), with the 12-month market performance up to 17.89% higher. […]
Bristol-Myers Squibb Co. (BMY): Street Finally Waking Up
Currently, there are 2.02B common shares owned by the public and among those 2.02B shares have been available to trade. Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 85 of these insider trades were purchases, […]
Why Should You Put Bristol-Myers Squibb Co. (NYSE: BMY) On Your Portfolio?
Currently, there are 2.02B common shares owned by the public and among those 2.02B shares have been available to trade. Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 85 of these insider trades were purchases, […]
Now Is A Suitable Moment For A Long-Term Purchase Of Bristol-Myers Squibb Co. (NYSE: BMY)
Currently, there are 2.10B common shares owned by the public and among those 2.03B shares have been available to trade. Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 85 of these insider trades were purchases, […]
Bristol-Myers Squibb Co. (BMY) Volatility Spurs A Quest For Clarity
Currently, there are 2.10B common shares owned by the public and among those 2.03B shares have been available to trade. Insiders at the company have transacted a total of 138 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 85 of these insider trades were purchases, […]
